New Treatment for Excessive Perspiration Approved By US FDA
A new treatment for primary axillary hyperhidrosis called Qbrexza (glycopyrronium) has been approved by the US Food And Drug Administration (FDA).
5266 articles
A new treatment for primary axillary hyperhidrosis called Qbrexza (glycopyrronium) has been approved by the US Food And Drug Administration (FDA).
The US Food And Drug Administration (FDA) has given the green light for tafenoquine (Krintafel), a new drug to fight malaria.
Having diabetes dramatically increases one’s risk of developing cancer, especially in women, as shown in a global review that involved nearly 20 milli...
Researchers have recently developed and validated an online health calculator called the Cardiovascular Disease Population Risk Tool (CVDPoRT) that ca...
The New York Times and USA Today bestselling author Diane Chamberlain talks about pursuing her writing passion while living with rheumatoid arthritis, a...
The fatty liver disease is a very common liver disease in the US. Learn more on Health Professional Radio.
Health experts in the UK are alerting that rates of the sexually transmitted infection, mycoplasma genitalium, may probably double in the next decade, b...
A new study began investigating the association between sensitivity to bitter tastes and the risk of cancer in women. Learn more on Health Professional Radio.
Two new studies show that consuming a daily low-dose of aspirin could possibly help women avoid ovarian cancer or promote their survival if the disease ...
Wounds Australia’s CEO Anne Buck returns to HPR to promote Wound Awareness Week 2018 and the comprehensive 5-Point Plan that her organization created ...